Bavituximab Recruiting Phase 2 Trials for Hepatocellular,Carcinoma Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03519997A Study of Pembrolizumab and Bavituximab in Patients With Advanced Hepatocellular Carcinoma